|
|
Volumn 11, Issue 2, 2001, Pages 105-111
|
|
CMO (cerasomol-cis-9-cetyl myristoleate) in the treatment of fibromyalgia: An open pilot study
|
|
Author keywords
Cerasomol cis 9 cetyl myristoleate; Clinical trial; CMO; Fibromyalgia; Symptom questionnaire
|
|
Indexed keywords
CERASOMOL 9 CETYL MYRISTOLEATE;
FATTY ACID;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
COGNITIVE DEFECT;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
FATIGUE;
FEMALE;
FIBROMYALGIA;
HUMAN;
INDIGESTION;
MALE;
MUSCLE SPASM;
PAIN;
PRIORITY JOURNAL;
RASH;
RATING SCALE;
SLEEP DISORDER;
SYMPTOM;
TREATMENT OUTCOME;
|
|
EID: 0034942669
PISSN: 13590847
EISSN: None
Source Type: Journal
DOI: 10.1080/13590840120060849 Document Type: Article |
|
Times cited : (4)
|
|
References (5)
|
